Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers (Q33688718)

28 July 2017

1 reference

title

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers (English)

1 reference

28 July 2017

Young MR

1

1 reference

PubMed ID

10408632

28 July 2017

Lathers DM

series ordinal

2

1 reference

28 July 2017

1 April 1999

1 reference

International Journal of Immunopharmacology

28 July 2017

1 reference

28 July 2017

21

1 reference

28 July 2017

241-252

1 reference

28 July 2017

4

1 reference

Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Interleukins and contrasuppression induce immune regression of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Update on immunology of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Effect of murine interferon alpha/beta on tumour-induced suppressor function

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Gene therapy approaches in urologic oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900008-9

7 January 2021

10.1016/S0192-0561(99)00008-9

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10408632